R&D

Hetero is a globally renowned vertically integrated pharmaceutical player engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Backed by 27 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Global Generics, Biosimilars and Custom Pharmaceutical Services. The company is among the largest producers of Active Pharmaceutical Ingredients in the world.

The Central Council for Research in Ayurvedic Sciences (CCRAS) is an autonomous body of the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy), Government of India. It is an apex body in India for the formulation, coordination, development and promotion of research on scientific lines in Ayurveda and Sowa-Rigpa system of medicine.

MSN Group is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. Established in the year 2003, MSN Group comprises of 330 API manufacturing plants (including one for Oncology), three finished dosage facility ( including one for Oncology)and a dedicated R&D Center . Our plants are ISO 9001-2000 certified, WHO: GMP, EU:GMP and USFDA approved.

API DIVISION : R&D DEPARTMENT

In 1870 the Maharaja of Vijanagaram first floated the idea of starting a Medical College in Lucknow. But the idea was watered down due to paucity of funds. In 1905 the visit of King-Emperor, George V, then Prince of Wales, inspired the idea of establishing a college to commemorate the occasion. The originator of this fine ideal to commemorate the occasion was late Raja Sir Tassadnq Rasul Khan of Jehangirabad to whom Sir Harcourt Butler wrote on 1st December 1905.

The Birla Institute of Technology & Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to "train young men and women able and eager to create and put into action such ideas, methods, techniques and information". The Institute is a dream come true of its founder late Mr G.D.Birla - an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi (Mahatma Gandhi).

Syngene International Ltd. is an innovation-focused global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngenes clientele includes world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife.

o2h group seeds new ideas in science, technology and green innovation. We work across boundaries and take a collaborative and shared approach to innovation, and therefore we co-invest, co-create and co-execute to bring these ideas to life.  o2h group is organised into 6 symbiotic verticals; o2h ventures, o2h discovery, o2h therapeutics, o2h technology, o2h co-work, and o2h community.

Post : Research Chemist (2-6 yrs)

The Institute for Stem Cell Science & Regenerative Medicine, Bangalore is an autonomous institute of the Department of Biotechnology, Government of India. inStem’s mandate is to establish collaborative research programs in the field of stem cell biology, regeneration and repair in development and disease and with translational emphasis. In order to develop strengths in focused areas, research at inStem is programmatic, and is driven through collaborative inter- disciplinary themes, addressing questions, which are beyond the scope of a single laboratory.

National Centre for Nanosciences and Nanotechnology, University of Mumbai (NCNNUM) has undertaken R&D and Training Programmes to meet some of the challenges of nanotechnology development. University of Mumbai will focus on a) R&D in Nanosciences and Nanotechnology leading to industry-ready technology and b) Development of human resources to implement the technology.